THE PREDICTIVE VALUE OF THE HEART SCORE FOR CORONARY LESIONS BASED ON THE SYNTAX SCORE IN PATIENTS WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROME

Thái Hảo Phan, Anh Tài Võ

Main Article Content

Abstract

Introduction: Non-ST-elevation acute coronary syndrome (NSTE-ACS) is prevalent in emergency settings, with lesion severity influencing treatment pathways. The SYNTAX score, determined through coronary angiography, accurately assesses lesion complexity but requires an invasive procedure. In contrast, the HEART score – based on clinical factors (History, ECG, Age, Risk factors, Troponin)—offers a non-invasive, rapid assessment tool. This study evaluates the HEART score’s effectiveness in predicting coronary lesion severity, as represented by the SYNTAX score, in NSTE-ACS patients. Methods: This cross-sectional study included 120 NSTE-ACS patients admitted to Trưng Vương Hospital from December 2023 to September 2024. Patients underwent HEART scoring and coronary angiography within 48 hours of admission. SYNTAX scores categorized patients into low (0–22), intermediate (23–32), or high-risk groups (≥33). Spearman’s correlation was used to assess the HEART-SYNTAX relationship, with receiver operating characteristic (ROC) analysis identifying the optimal HEART score cutoff for predicting SYNTAX ≥23. Results: The cohort’s mean age was 63.9 years, with 66.7% male. Common risk factors included hypertension (80.8%), hyperlipidemia (73.3%) and diabetes (25.8%). A significant positive correlation (ρ = 0.819, p < 0.001) was observed between HEART and SYNTAX scores, with higher HEART scores reflecting greater lesion complexity. ROC analysis yielded an area under the curve (AUC) of 0.912 (95% CI, 0.862–0.963), with a HEART score cutoff of 5 showing 90.6% sensitivity and 83.9% specificity for predicting moderate-to-high SYNTAX scores (≥ 23). Conclusion: The HEART score is an effective, non-invasive predictor of coronary lesion complexity in NSTE-ACS patients, correlating significantly with SYNTAX scores. A HEART score of  ≥ 5 accurately identifies patients at risk for severe coronary disease, supporting its use in rapid, non-invasive risk stratification and facilitating timely intervention in emergency settings.

Article Details

References

1. Brown JC, Gerhardt TE, Kwon E. Risk Factors for Coronary Artery Disease. StatPearls. StatPearls Publishing Copyright © 2024, StatPearls Publishing LLC.; 2024:
2. Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). European Heart Journal. 2023;doi:10.1093/eurheartj/ehad191
3. Cedro AV, Mota DM, Ohe LN, et al. Association between Clinical Risk Score (Heart, Grace and TIMI) and Angiographic Complexity in Acute Coronary Syndrome without ST Segment Elevation. Arq Bras Cardiol. Aug 2021;117(2):281-287. Associação entre Escores de Risco Clínico (HEART, GRACE e TIMI) e Complexidade Angiográfica na Síndrome Coronária Aguda sem Elevação do Segmento ST. doi:10.36660/ abc.20190417
4. Garg S, Sarno G, Serruys PW, et al. Prediction of 1-Year Clinical Outcomes Using the SYNTAX Score in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) Trials. JACC: Cardiovascular Interventions. 2011/01/01/ 2011;4(1):66-75. doi:https://doi.org/10.1016/j.jcin.2010.09.017
5. Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(3):e18-e114. doi:doi:10.1161/CIR.0000000000001038
6. Magro M, Nauta S, Simsek C, et al. Value of the SYNTAX score in patients treated by primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: The MI SYNTAXscore study. American Heart Journal. 2011/04/01/ 2011;161(4):771-781. doi:https://doi.org/10.1016/j.ahj.2011.01.004
7. Maltes S, Paiva MS, Madeira S, et al. Correlation between NSTE-ACS risk scores with Syntax: can we predict coronary lesion complexity before angiography? European Heart Journal. 2022; 43(Supplement_2)doi:10.1093/ eurheartj/ehac544.1300
8. Rott D, Leibowitz D. STEMI and NSTEMI are two distinct pathophysiological entities. Eur Heart J. Nov 2007;28(21):2685; author reply 2685. doi:10.1093/eurheartj/ehm368.